Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Primary Diagnosis of GAD (DSM IV, 300.02) as established by the clinician using all sources of data including the MINI structured interview
HAM A score ³20 at the Screening (Study Day -7) and Baseline (Study Day 1) Visits by observer rating
Good health as determined by medical history, physical examination, vital signs, electrocardiography (ECG), and clinical laboratory measurements
Covi Anxiety Scale total score ³9 and Raskin Depression Scale total score £7 at the Screening Visit (to ensure predominance of anxiety symptoms over depression symptoms)
Age 18 to 65 (inclusive)
You may not be if
Patients with most other current DSM-IV Axis I disorders.
Patients with current or past schizophrenia, Psychotic disorder
Delirium, dementia, amnestic, and other clinically significant cognitive disorders
Bipolar or schizoaffective disorder
Benzodiazepine abuse or dependence; and/or Factitious disorder.
